We should not settle for low-level evidence but should always use the best available evidence

Kailash NARAYAN; Linda MILESHKIN; Sylvia VAN-DYK; David BERNSHAW; Pearly KHAW; Srinivas KONDALSAMY-CHENNAKESAVAN.
Journal of Gynecologic Oncology ; : 349-351, 2014.
Artículo en Inglés | WPRIM | ID: wpr-202214

Documentos relacionados

  1. Locally advanced cervical cancer: how the improvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities.
  2. In-vivo quality assurance of dynamic tumor tracking (DTT) for liver SABR using EPID images.
  3. Selective de-implementation of routine in vivo dosimetry.
  4. Isodose surface differences: A novel tool for the comparison of dose distributions.
  5. We should not settle for low-level evidence but should always use the best available evidence.
  6. Shall we settle for low-level evidence?
  7. Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning.
  8. Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer.
  9. Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques.
  10. [Short Review of the History of Radiotherapy for Intraocular Tumours].